Role of interleukins in the regulation of basophil development and secretion
- 1 January 2010
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Hematology
- Vol. 17 (1), 60-66
- https://doi.org/10.1097/moh.0b013e328331fae9
Abstract
It is well appreciated that differentiation, growth, and function of basophils are regulated by a network of cytokines, and that these cells express a unique composition of surface receptors including interleukin-binding sites. In the current article, most recent discoveries around cytokine regulation of basophils are discussed and compared with previous data. Confirming previous studies, the most potent growth factor for basophils remains interleukin (IL)-3, followed by granulocyte–macrophage colony-stimulating factor and IL-5. These cytokines also act on mature basophils through specific receptors, thereby mediating adhesion, migration, and releasability. Other molecules regulating basophil function are chemokines such as IL-8 or eotaxin and IL-33. Especially IL-33 has been described as a novel basophil regulator. All cytokines act on basophils via specific receptors and signal transduction pathways. The present article provides a summary of our knowledge on cytokine regulation of basophils and receptor expression, with emphasis on most recent developments in the field. Basophil regulation by cytokines in health and disease may be a more complex process than has been considered previously. Some of the affected cytokine cascades, receptors, and signal transduction molecules may serve as targets of therapy in ‘basophil activation disorders’ in the future.Keywords
This publication has 61 references indexed in Scilit:
- IL-3 Induces Basophil Expansion In Vivo by Directing Granulocyte-Monocyte Progenitors to Differentiate into Basophil Lineage-Restricted Progenitors in the Bone Marrow and by Increasing the Number of Basophil/Mast Cell Progenitors in the SpleenThe Journal of Immunology, 2009
- Human Basophils Secrete IL-3: Evidence of Autocrine Priming for Phenotypic and Functional Responses in Allergic DiseaseThe Journal of Immunology, 2009
- Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33Blood, 2009
- A novel IL-1 family cytokine, IL-33, potently activates human eosinophilsJournal of Allergy and Clinical Immunology, 2008
- Activated status of basophils in chronic urticaria leads to interleukin-3 hyper-responsiveness and enhancement of histamine release induced by anti-IgE stimulusBritish Journal of Dermatology, 2008
- Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cellsCytokine, 2007
- Analysis of the lineage relationship between mast cells and basophils using the c-kit D816V mutation as a biologic signatureJournal of Allergy and Clinical Immunology, 2005
- Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine.The Journal of Experimental Medicine, 1994
- RANTES and related chemokines activate human basophil granulocytes through different G protein‐coupled receptorsEuropean Journal of Immunology, 1993
- Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils.The Journal of Experimental Medicine, 1992